Pharmaceuticals - Community Register


List of refusals for human medicinal products


Product name: Rescupase
Active substance: Saruplase
Indication: Thrombolytic therapy for acute myocardial infarction in patients presenting within 6 hours of symptom onset
Marketing Authorisation Holder: Grünenthal GmbH

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
5/08/1999 Centralised - Refusal of marketing authorisation EMEA/H/C/195 (1999)2504 of 26/07/1999